Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: early response during bacterial meningitis.
A local defense mechanism in bacterial meningitis was evaluated in humans by measuring complement-mediated opsonic activity (CMOA) in normal and infected cerebrospinal fluid (CSF) with a complement-dependent phagocytic bactericidal assay. CMOA was absent in normal untreated CSF and remained undetectable in 20 samples of CSF from patients with viral meningitis and five samples from patients with acute meningococcemia. In contrast, 15 of 27 samples of CSF from patients with acute bacterial meningitis had a measurable CMOA, which was correlated with protein concentrations (P less than 0.01) and C4 hemolytic activity (P less than 0.001) in the CSF. A favorable outcome of bacterial meningitis was associated with the presence of CMOA in CSF (P less than 0.005). Recovery was also correlated with higher levels of C4 (P less than 0.01) and C3 (P less than 0.05) in CSF and with lower concentrations of microorganisms in the sample of CSF collected at the time of admission (P less than 0.01). Thus, CMOA, although absent in normal CSF, can appear in CSF during acute bacterial meningitis, particularly in patients who recover completely.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000175:diagnosis / Q000276:immunology*; D002648:Child; D002675:Child, Preschool; D003165:Complement System Proteins / Q000134:cerebrospinal fluid*; D005260:Female; D006801:Humans; D008297:Male; D008581:Meningitis / Q000175:diagnosis / Q000276:immunology*; D008587:Meningitis, Viral / Q000276:immunology; D008589:Meningococcal Infections / Q000276:immunology; D008875:Middle Aged; D009895:Opsonin Proteins / Q000134:cerebrospinal fluid*; D010587:Phagocytosis; D011379:Prognosis; D018805:Sepsis / Q000276:immunology; D013211:Staphylococcus aureus / Q000276:immunology
D009895:Opsonin Proteins; D003165:Complement System Proteins